跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,919 条关于
“Apellis Pharma”
全部
9,919
临床试验
4,348
药物
1,119
机构
1,224
资讯
3,228
去年
Apellis Pharmaceuticals' C3G/IC-MPGN Drug Shows Promise Amidst Syfovre Setbacks
去年
Regulatory Roundup: Key Approvals and Submissions in Late September 2024
去年
Emerging Therapies Show Promise for Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN)
上个月
Biogen Beats Q2 Estimates as Rare Disease Portfolio and Leqembi Drive Growth, Raises 2026 Revenue Outlook
去年
Sarepta Therapeutics Receives Buy Rating Due to Strong Elevidys Launch and Promising Pipeline
去年
FDA Rejects Astellas' Izervay Update; Cytokinetics and Bayer Announce Aficamten Licensing Deal
3个月前
Dry AMD Market Poised for 19.2% CAGR Growth Through 2036 as Pipeline Diversifies Beyond Complement Inhibition
去年
Apellis' Syfovre Faces Third Rejection by EU's CHMP for Geographic Atrophy
去年
FDA Initiates Review of Roche's Monthly Injectable Crovalimab for Rare Blood Disorder PNH
去年
Apellis Faces Setback as EMA Rejects Pegcetacoplan, Mizuho Lowers Price Target
第 1 页,共 323 页
上一页
下一页